Biotts S.A. and Bioton S.A. have signed a Proof of Concept agreement to test the feasibility of transporting insulin through the skin using the patented MTC-Y carrier. Bioton will supply insulin for patches, which will enable long-lasting drug delivery through the skin using a transdermal system from Biotts. After the PoC phase, the biotech will […]
Read the full articleThe Wroclaw-based biotechnology company has become the first in the world to transport the peptides liraglutide and semaglutide through the skin. The last is a substance used in drugs such as the record-breaking Ozempic and Wegovy from the Danish company NovoNordisk. Transdermally delivered substances belong to the group of glucagon-like peptide-1 (GLP-1) analogs used to […]
Read the full articleNestmedic S.A., developer of fetal well-being monitoring technology consisting of the Pregnabit Pro device and the Pregnabit Cloud platform, has signed a distribution agreement with Synektik. The Synektik Group provides IT solutions, cutting-edge technology and a full range of services and support to medical institutions in the fields of radiology, oncology, cardiology and neurology. The […]
Read the full articleXTPL placed all 275,000 Series V shares at an issue price of PLN 133. Investor interest was huge and exceeded the value of the offer by several times. The shares will represent 11.9% of the company’s shares. The funds raised from the share issue will be used to commercialise XTPL’s technology in the three business […]
Read the full articleTerrabio, a biotechnology company based in Wrocław, has developed the first mobile genetic analyser available in Poland. This device enables food manufacturers to rapidly detect viruses, bacteria, fungi, or protozoa. The R&D phase is nearing completion, and the company is currently testing the device with potential customers. This marks a significant milestone in Terrabio’s development, […]
Read the full articleOn 16th February 2023, Genomtec S.A. debuted on the Main Market of the Warsaw Stock Exchange. The company had been listed on the New Connect market since March 2021. At the opening, the company’s stock price rose 2.16% to PLN 14.2. Genomtec has clear plans for growth: it has initiated an M&A process with Clairfield Partners […]
Read the full article